Agree it should go much higher. I'm only considering consistent 30% sales growth each quarter, consistent with what we did last quarter, plus the $1.94M for SK. No Fluticare.
Why the anticipated dip for Q4 for existing products?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.